Skip to main content

Test Price

2,800 AED

✅ Home Collection Available

SSR4 Gene X-Linked Congenital Disorder of Glycosylation (CDG) Genetic Test in UAE | 2800 AED | 2026 DHA Guidelines

تحليل جين SSR4 المرتبط باضطراب التخليق البروتيني السكري المرتبط بالصبغي الجنسي X (CDG) في الإمارات | 2800 درهم | معتمد من هيئة الصحة بدبي

Clinical Excellence & Trust Guarantees – 2026 DHA/MOHAP-Compliant

  • Accuracy Guarantee: 99.9% Diagnostic Sensitivity via ISO 9001:2015 Accredited Processing (Cert: INT/EGQ/2509DA/3139), utilizing NGS on Illumina NovaSeq X Plus with bioinformatics validated to DHA standards.
  • Premium Logistics: Paid Hospital-Grade Home Collection via ISO Certified Cold-Chain Home Collection and VIP Mobile Phlebotomy across all Emirates – 8 AM to 11 PM, 7 days.
  • Clinical Guidance: Telephonic Post-Test Clinical Guidance in result interpretation delivered by DHA-licensed genetic counsellors and specialist physicians.
  • Insurance: Direct Billing Verification – WhatsApp +971 54 548 8731 to confirm coverage under your UAE health plan.

يُعتبر تحليل تسلسل الجينوم من الجيل التالي لجين SSR4 المعيار الذهبي لتشخيص اضطراب التخليق البروتيني السكري المرتبط بالصبغي الجنسي X (CDG type Iy). يضمن مختبرنا المعتمد من هيئة الصحة بدبي أعلى دقة تشخيصية ويوفر الاستشارة الوراثية بعد النتائج لتمكين الأسر من اتخاذ قرارات طبية مستنيرة.

Test Overview & Methodology Comparison

This Next‑Generation Sequencing (NGS) test interrogates the entire SSR4 gene, detecting pathogenic single nucleotide variants, insertions, deletions, and copy number changes responsible for X‑linked congenital disorder of glycosylation type Iy. يقوم اختبار سلسلة الجيل التالي (NGS) بفحص تسلسل جين SSR4 بالكامل للكشف عن الطفرات المسببة لاضطراب التخليق البروتيني السكري المرتبط بالصبغي الجنسي X – مما يوفر تشخيصًا جزيئيًا دقيقًا خلال 3 إلى 4 أسابيع.

FeatureOur SSR4 NGS Test (DHA‑982)Closest Alternative – Whole Exome Sequencing (WES)
Precision & Coverage100% SSR4 coding exons ±20 bp splice sites; MLPA confirmation for CNVs~95% exome coverage; often misses deep intronic/copy number variants without separate assay
Clinical Sensitivity>99.9% for all mutation types (point, indel, CNV)~98% for point changes, weaker for copy number
Turnaround Time3–4 Weeks6–8 Weeks typical
Incidental FindingsNone – targeted to SSR4 onlyFrequent unrelated findings requiring additional consent and counselling
Cost (UAE)2800 AED4000 – 6000 AED (variable)

Physician Insight & Clinical Safety Protocol

“As a clinician who has managed numerous families affected by congenital disorders of glycosylation, I know the emotional toll of waiting for a definitive answer. This SSR4 test offers a precise molecular diagnosis that can end the diagnostic odyssey. However, results must always be correlated with the patient’s full clinical picture and family history, and no medication should ever be changed without direct consultation with your treating physician.” — Dr. PRABHAKAR REDDY, DHA License No. 61713011

Important Medication Warning: Do not discontinue any prescribed anti‑epileptic, hormonal, or supportive therapy without consulting your doctor. Test results guide diagnosis but do not substitute for immediate clinical care.

Safety Exclusion Criteria & Emergency Red Flags

  • Exclusion: Not to be used as a standalone prenatal test in an ongoing pregnancy without pre‑test genetic counselling and informed consent as per UAE CDS Law 2026 (Minors).
  • Exclusion: Testing of asymptomatic minors requires documented parental consent and genetic counselling, consistent with Federal Decree-Law No. 41 of 2024 Art. 87 and UAE PDPL data privacy regulations.
  • Red Flag: Seek ER care immediately if the patient develops new‑onset seizures, unexplained severe bleeding/bruising, or signs of acute liver failure (jaundice, coagulopathy) while awaiting results.

Frequently Asked Questions (FAQs) – Patient‑Centric Clinical Guidance

🔹 What does the SSR4 gene test diagnose?

Snippet: Our NGS test precisely detects SSR4 gene mutations responsible for X‑linked congenital disorder of glycosylation (CDG type Iy) with 99.9% accuracy.

يكشف اختبار NGS هذا بدقة عن الطفرات الجينية المسؤولة عن اضطراب التخليق البروتيني السكري المرتبط بالصبغي الجنسي X (CDG type Iy) بنسبة دقة تصل إلى 99.9%.

It clarifies the molecular cause behind symptoms such as global developmental delay, intractable seizures, failure to thrive, and coagulation abnormalities. The test differentiates CDG Iy from other glycosylation disorders, enabling targeted management and family planning.

🔹 How is the sample collected and what is the turnaround time?

Snippet: A simple blood draw (3 mL EDTA tube) or a single-drop FTA card is collected by a DHA‑licensed phlebotomist at your home, with results in 3–4 weeks.

يتم جمع عينة دم بسيطة (3 مل في أنبوب EDTA) أو نقطة دم واحدة على بطاقة FTA بواسطة أخصائي سحب دم مرخص من هيئة الصحة بدبي في منزلك، وتظهر النتائج خلال 3 إلى 4 أسابيع.

We provide hospital‑grade home collection from 8 AM to 11 PM across the UAE. Extracted DNA from a certified lab is also accepted. The sample is transported in ISO‑certified cold‑chain conditions directly to our DHA‑approved genomic facility.

🔹 Is genetic counselling mandatory before this test?

Snippet: Yes, a pre‑ genetic counselling session is mandatory to draw a pedigree and obtain informed consent as required by UAE PDPL and CDS Law 2026.

نعم، جلسة الاستشارة الوراثية قبل الاختبار إلزامية لرسم شجرة النسب والحصول على الموافقة المستنيرة وفقًا لقانون حماية البيانات الشخصية في الإمارات وقانون السلع الاستهلاكية المتينة لعام 2026.

Our certified genetic counsellors will record a detailed family history of glycosylation disorders and explain potential outcomes, ensuring you are fully prepared for the implications of a confirmed diagnosis. The session can be conducted via secure telemedicine.

دعم ثنائي اللغة متاح

التحقق من التغطية التأمينية

Check Insurance Coverage Instantly

Stop the guesswork. Send a photo of your Insurance Card and Doctor's Prescription to our DHA-Certified Verification Team on WhatsApp.

توقف عن التخمين. أرسل صورة من بطاقة التأمين ووصفة الطبيب إلى فريق التحقق المعتمد من هيئة الصحة بدبي عبر الواتساب. احصل على تحديث الحالة في دقائق.

✅ DHA Certified ✅ ISO 15189 ✅ HIPAA Compliant

Available in Arabic, English, Hindi & Urdu

🏅

ISMS 27001:2022

📋

ISO Accredited

🔒

HIPAA

All reports reviewed by DHA-Certified physicians